Financial Results : Tibbiyah posts 14% drop in 2021 net profit to SAR 82.3 mln

Tibbiyah posts 14% drop in 2021 net profit to SAR 82.3 mln

13/03/2022 Argaam Exclusive

View other reports

Arabian International Healthcare Holding Co. (Tibbiyah) posted a 14% decline in net profit after Zakat and tax to SAR 82.3 million in 2021, compared to SAR 95.8 million a year earlier. 



Financials (M)

Item 2020 2021 Change‬
Revenues 818.69 618.54 (24.4 %)
Gross Income 198.38 143.52 (27.7 %)
Operating Income 98.28 70.10 (28.7 %)
Net Income 95.79 82.31 (14.1 %)
Average Shares 20.00 20.00 -
EPS (Riyals) 4.79 4.12 (14.1 %)

The company attributed the profit drop to a decline in annual revenue to SAR 618.5 million, from SAR 818.7 million in 2020.

 

On the other hand, Tibbiyah mitigated the negative impact on its annual net profit, as it focused on operating cost efficiencies and working capital management. Tibbiyah’s net profit margins also increased to 13% in 2021, from 12% in 2020.



Current Half Annual Comparison (M)

Compared With The
Item H2 2020 H2 2021 Change‬
Revenues 625.04 369.30 (40.9 %)
Gross Income 159.44 85.79 (46.2 %)
Operating Income 109.27 60.70 (44.4 %)
Net Income 126.75 77.22 (39.1 %)
Average Shares 20.00 20.00 -
EPS (Riyals) 6.34 3.86 (39.1 %)

Shareholders' equity, excluding minority interest, saw a slight decline to SAR 332.1 million in 2021, from SAR 332.1 million in 2020.



Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
H1 2012 - - - - - -
H2 2012 - - - - - -
H1 2013 - - - - - -
H2 2013 - - - - - -
H1 2014 - - - - - -
H2 2014 - - - - - -
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 193.65 - 38.94 - (10.98) -
H2 2020 625.04 - 159.44 - 109.27 -
H1 2021 249.24 28.7 % 57.73 48.2 % 9.40 185.5 %
H2 2021 369.30 (40.9 %) 85.79 (46.2 %) 60.70 (44.4 %)
2021 618.54 (24.4 %) 143.52 (27.7 %) 70.10 (28.7 %)


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS Before XO Items
H1 2012 - - - - - -
H2 2012 - - - - - -
H1 2013 - - - - - -
H2 2013 - - - - - -
H1 2014 - - - - - -
H2 2014 - - - - - -
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 (30.96) - (1.55) - (30.96) (1.55)
H2 2020 126.75 - 6.34 36.37 90.37 4.52
H1 2021 5.10 116.5 % 0.25 - 5.10 0.25
H2 2021 77.22 (39.1 %) 3.86 14.63 62.59 3.13
2021 82.31 (14.1 %) 4.12 14.63 67.69 3.38

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
H1 2012 - - -
H2 2012 - - -
H1 2013 - - -
H2 2013 - - -
H1 2014 - - -
H2 2014 - - -
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 24.23 % 12.88 % 7.26 %
H1 2021 24.84 % 14.38 % 10.92 %
H2 2021 23.20 % 12.41 % 10.94 %
2021 23.20 % 12.41 % 10.94 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
H1 2012 - - - -
H2 2012 - - - -
H1 2013 - - - -
H2 2013 - - - -
H1 2014 - - - -
H2 2014 - - - -
H1 2015 - - - -
H2 2015 - - - -
H1 2016 - - - -
H2 2016 - - - -
H1 2017 - - - -
H2 2017 - - - -
H1 2018 - - - -
H2 2018 - - - -
H1 2019 - - - -
H2 2019 - - - -
H1 2020 20.00 - - -
H2 2020 20.00 4.79 2.97 16.62
H1 2021 20.00 6.59 4.77 12.74
H2 2021 20.00 4.12 3.38 16.67

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
H1 2012 - - -
H2 2012 - - -
H1 2013 - - -
H2 2013 - - -
H1 2014 - - -
H2 2014 - - -
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 - - -
H1 2021 - - -
H2 2021 - - -

Business Segments (Million)

Compared With The
Period Medical devices Medical supplies
Q2 2021 123.93 125.30
Q4 2021 180.28 189.03

Current
Market Cap (M Riyal) 834.00
Enterprise Value (EV) (M) 1,275.97
Shares Outstanding ((M)) 20.00
Book Value (BV) ( Riyal) 15.33
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) More than 100
Price/book 2.72

Share Price

Arabian International Healthcare Holding Co. (TIBBIYAH)


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.